Your session is about to expire
← Back to Search
Intraocular Lens
Model DIU for Cataract
N/A
Waitlist Available
Research Sponsored by Johnson & Johnson Surgical Vision, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 month
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing new special lenses to help people with cataracts and astigmatism see better by replacing their cloudy natural lens and improving how light is focused in the eye.
Eligible Conditions
- Cataract
- Pseudoaphakia
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 month
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Rotational Stability of IOL
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: TECNIS Synergy Toric IIExperimental Treatment1 Intervention
Model DFW
Group II: Eyhance Toric II IOLExperimental Treatment1 Intervention
Model DIU
Group III: TECNIS Toric 1-Piece IOLActive Control1 Intervention
Model ZCT
Find a Location
Who is running the clinical trial?
Johnson & Johnson Surgical Vision, Inc.Lead Sponsor
36 Previous Clinical Trials
8,320 Total Patients Enrolled
31 Trials studying Cataract
7,091 Patients Enrolled for Cataract
Johnson & Johnson Surgical Vision, Inc. Clinical TrialStudy DirectorJohnson & Johnson Surgical Vision, Inc.
8 Previous Clinical Trials
4,249 Total Patients Enrolled
7 Trials studying Cataract
4,214 Patients Enrolled for Cataract
Other Trials to Consider
Popular Categories
Learn More About These Treatments
Share this study with friends
Copy Link
Messenger